BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15341486)

  • 1. Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin.
    Urbaniak MD; Bingham JP; Hartley JA; Woolfson DN; Caddick S
    J Med Chem; 2004 Sep; 47(19):4710-5. PubMed ID: 15341486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New complex of post-activated neocarzinostatin chromophore with DNA: bulge DNA binding from the minor groove.
    Kwon Y; Xi Z; Kappen LS; Goldberg IH; Gao X
    Biochemistry; 2003 Feb; 42(5):1186-98. PubMed ID: 12564921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalent bendamustine and melphalan derivatives as anticancer agents.
    Scutaru AM; Wenzel M; Gust R
    Eur J Med Chem; 2011 May; 46(5):1604-15. PubMed ID: 21371790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced hydrolytic stability and water solubility of an aromatic nitrogen mustard by conjugation with molecular umbrellas.
    Vijayaraghavan S; Jing B; Vrablik T; Chou TC; Regen SL
    Bioconjug Chem; 2003; 14(3):667-71. PubMed ID: 12757393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PNA-nitrogen mustard conjugates are effective suppressors of HER-2/neu and biological tools for recognition of PNA/DNA interactions.
    Zhilina ZV; Ziemba AJ; Nielsen PE; Ebbinghaus SW
    Bioconjug Chem; 2006; 17(1):214-22. PubMed ID: 16417271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorambucil-adducts in DNA analyzed at the oligonucleotide level using HPLC-ESI MS.
    Mohamed D; Mowaka S; Thomale J; Linscheid MW
    Chem Res Toxicol; 2009 Aug; 22(8):1435-46. PubMed ID: 19621941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
    Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
    Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monofunctional derivative of melphalan: preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adducts.
    Tilby MJ; McCartney H; Gould KA; O'Hare CC; Hartley JA; Hall AG; Golding BT; Lawley PD
    Chem Res Toxicol; 1998 Oct; 11(10):1162-8. PubMed ID: 9778312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of enzymatic, acidic and thermal hydrolysis of DNA on the occurrence of cross-linked melphalan DNA adducts.
    Van den Driessche B; Lemière F; Witters E; Van Dongen W; Esmans EL
    Rapid Commun Mass Spectrom; 2005; 19(4):449-54. PubMed ID: 15655794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic ligands for apo-neocarzinostatin.
    Caddick S; Muskett FW; Stoneman RG; Woolfson DN
    J Am Chem Soc; 2006 Apr; 128(13):4204-5. PubMed ID: 16568976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of cyclic nitrogen mustards based on carnitine framework.
    Leiris S; Lucas M; Dupuy d'Angeac A; Morère A
    Eur J Med Chem; 2010 Sep; 45(9):4140-8. PubMed ID: 20615582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the N-lost drugs melphalan and bendamustine: synthesis and cytotoxicity of a new set of dendrimer-drug conjugates as tumor therapeutic agents.
    Scutaru AM; Wenzel M; Scheffler H; Wolber G; Gust R
    Bioconjug Chem; 2010 Oct; 21(10):1728-43. PubMed ID: 20849062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of loop dynamics in the neocarzinostatin chromophore binding and release mechanisms.
    Wang B; Merz KM
    Phys Chem Chem Phys; 2010 Apr; 12(14):3443-9. PubMed ID: 20336247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nucleosome structure on DNA interstrand cross-linking reactions.
    Millard JT; Spencer RJ; Hopkins PB
    Biochemistry; 1998 Apr; 37(15):5211-9. PubMed ID: 9548752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulations investigation of neocarzinostatin chromophore-releasing pathways from the holo-NCS protein.
    Zhao X; Wang S; Gao XF; Huang XR; Sun CC
    J Struct Biol; 2010 Jan; 169(1):14-24. PubMed ID: 19747549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
    Napier MA; Goldberg IH
    Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of a potential metabolite of the carcinostatic bendamustin (Cytostasen)].
    Werner W; Letsch G; Ihn W; Sohr R; Preiss R
    Pharmazie; 1991 Feb; 46(2):113-4. PubMed ID: 1852759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial identification of a novel consensus sequence for the covalent DNA-binding polyamide tallimustine.
    Sunavala-Dossabhoy G; Van Dyke MW
    Biochemistry; 2005 Feb; 44(7):2510-22. PubMed ID: 15709763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid bilayer-assisted release of an enediyne antibiotic from neocarzinostatin chromoprotein.
    Hariharan P; Sudhahar CG; Chou SH; Chin DH
    Biochemistry; 2010 Sep; 49(35):7722-32. PubMed ID: 20712297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro evaluation of quaternary ammonium derivatives of chlorambucil and melphalan, anticancer drugs designed for the chemotherapy of chondrosarcoma.
    Giraud I; Rapp M; Maurizis JC; Madelmont JC
    J Med Chem; 2002 May; 45(10):2116-9. PubMed ID: 11985479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.